Anna Niwinska
0000-0001-5955-3556
Maria Sklodowska-Curie National Research Institute of Oncology
103 papers found
Refreshing results…
The role of stromal immune microenvironment in the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer
Assessment of the usefulness of prognostic Van Nuys Prognostic Index in the treatment in ductal carcinoma in situ in 15-year observation
Type of Recurrence, Cause of Death and Second Neoplasms among 737 Patients with Ductal Carcinoma In Situ of the Breast—15-Year Follow-Up
Limited Practical Utility of Liquid Biopsy in the Treated Patients with Advanced Breast Cancer
Pathological outcomes of HER2-positive early breast cancer patients treated with neoadjuvant trastuzumab or dual anti-HER2 therapy and carboplatin with docetaxel: A Maria Sklodowska-Curie National Research Institute of Oncology experience.
Prognostic and predictive value of neutrophil/lymphocyte ratio in patients with triple-negative and HER2-positive breast cancer undergoing neoadjuvant systemic therapy.
Validation of the Van Nuys Prognostic Index in 737 patients with ductal carcinoma in situ (DCIS) treated at Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Effects of BRCA Germline Mutations on Triple-Negative Breast Cancer Prognosis
Prognostic and predictive value of neutrophil/lymphocyte ratio in patients with triple-negative and HER2-positive breat cancer undergoing neoadjuvant systemic therapy
Radioterapia chorych na raka piersi
Praktyczne aspekty radioterapii raka piersi
“Good Risk”: low-risk patients with ductal carcinoma in situ (DCIS) benefit from whole breast radiotherapy after breast conservation surgery (BCS)–long-term follow-up.
The body mass index (BMI) and the effectiveness of the fulvestrant as treatment postmenopausal metastatic breast cancer patients
Neoadjuvant treatment of patients with TNBC early breast cancer 4 × AC and carboplatin with paclitaxel – is safe option of treatment?
Ocena znaczenia parametrów molekularnych: CD2 AND CD44, AR i TILs w prognozowaniu nawrotów choroby u chorych na potrójnie ujemnego raka piersi
Diagnostyka i leczenie raka przewodowego przedinwazyjnego piersi
The role of SWI/SNF chromatin remodelling complex ATPase subunit - BRM in TNBC
Are anthracyclines needed for the neoadjuvant treatment of patients with HER2-positive early breast cancer?
Should radiotherapy be succeed tumorectomy in patients with low risk ductal carcinoma in situ (DCIS) when using Van Nuys Prognostic Index based treatment?
Improving Fertility Preservation in Breast Cancer Patients
Missing publications? Search for publications with a matching author name.